New Products

BROOKLYN, N.Y. — Cumberland Packing Corp.'s In the Raw sweetener brand announced Sugar in the Raw Organic White, an organic, unbleached cane sugar. National distribution is set to begin this month in leading grocers and specialty health food stores across the United States.

NEW YORK — VR1 on Tuesday announced the availability of Ausanil, a new non-prescription homeopathic nasal spray formulated to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions. 

SILVER SPRING, Md. — The Food and Drug Administration last week approved Amneal Pharmaceuticals' abbreviated new drug application for atovaquone oral suspension USP, 750-mg/5-mL. 

Atovaquone is the generic equivalent of GlaxoSmithKline's Mepron, indicated for the prevention of Pneumocystis jiroveci pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole.

LOS ANGELES — OPI Products, a subsidiary of Coty, has collaborated with Coca-Cola to create a line of OPI nail lacquers inspired by several of the company’s most recognized brands, including Coca-Cola, Diet Coke, Coke Zero, Cherry Coke, Vanilla Coke, Sprite and Fanta.

The line of limited-edition nail lacquers will launch internationally in June.

SUMMIT, N.J. — Celgene on Friday announced that the Food and Drug Administration has approved Otezla (apremilast), the company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of adult patients with active psoriatic arthritis. A chronic disorder, psoriatic arthritis is characterized by pain, stiffness, swelling and tenderness of the joints, inflammation of specific ligaments and tendons, and a decrease in physical functioning. Otezla is the only FDA-approved oral treatment for psoriatic arthritis.

CONCORD, N.C. —  S&D Beverage Innovations, a division of S&D Coffee, a custom coffee roaster and blender of iced tea for the food service industry, announced the introduction of MilkSplash, a new milk flavoring for parents who want their kids to drink more milk and make health-conscious beverage choices.

MilkSplash will launch this week in select Target stores and will debut at Walmart and other retailers in April. The product comes in flavors like Cocoa Loco, Sir Strawberry Swirl, Orange Cream Dream, Cookies 'N Cream and Jammin' Banana.

SOUTH SAN FRANCISCO, Calif. — Genentech announced that the Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, or CIU, which is a form of chronic hives.

CIU is diagnosed when hives occur without cause, spontaneously present and reoccur for more than six weeks, the company said. The symptoms include swelling, severe itch, pain and discomfort that may last for months and, in some cases, years. 

NEW YORK — Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday. 

House dust mite-allergy is associated with allergic asthma and affects more than 30 million Americans.